Literature DB >> 3622293

[A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis)].

G Brunner, O Klinge.   

Abstract

Three females had suffered, two for many years, from bouts of a liver disease of unknown origin, which clinically, histologically and biochemically fulfills the criteria of chronic destructive non-suppurative cholangitis. None of the patients had antimitochondrial antibodies, but all had antinuclear antibodies at high titres. Two of them are mother and daughter; the latter has two daughters (aged 10 and 12 years), both of whom have antinuclear antibodies at low titres but no abnormal liver function tests. The female family members of the third patient also had antinuclear antibodies in their serum with normal liver enzyme tests. None of the patients was taking any drugs. Contrary to true chronic destructive nonsuppurative cholangitis (primary biliary cirrhosis), in the three patients immunosuppressive treatment with azathioprine (Imurek) and prednisone (Decortin) was successful. It is suggested that the described disease be called immunocholangitis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622293     DOI: 10.1055/s-2008-1068269

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  15 in total

1.  Is the new diagnostic scoring system of Zeniya and colleagues useful for autoimmune liver diseases?

Authors:  Norio Horiike; Morikazu Onji
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

2.  Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model.

Authors:  Mikio Zeniya; Fumitoki Watanabe; Toshio Morizane; Minoru Shibata; Shiro Maeyama; Masayoshi Kage; Yasuni Nakanuma; Gotaro Toda
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 3.  Treatment of autoimmune cholangitis.

Authors:  L Mohr; T Heintges; F Hensel; C Niederau; D Häussinger
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

4.  Autoimmune cholangiopathy and high-output heart failure in a patient with graves disease.

Authors:  Deepak Venkat; Dylan Wirtz; Tushar Patel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

5.  Autoimmune cholangitis.

Authors:  J Heathcote
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

6.  A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases.

Authors:  K W Burak; S J Urbanski; M G Swain
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

7.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 8.  [Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].

Authors:  C P Strassburg; M P Manns
Journal:  Internist (Berl)       Date:  2004-01       Impact factor: 0.743

Review 9.  Overlap syndromes of autoimmune hepatitis: what is known so far.

Authors:  Marilena Durazzo; Alberto Premoli; Sharmila Fagoonee; Rinaldo Pellicano
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.